Addressing platelet insecurity – A national call to action

Eric Gehrie: Honorarium from Cerus Corporation; Consultancies from Grifols Diagnostics and Instrumentation Laboratories. Editorial Board, Transfusion. Pampee P. Young: Consultancy from Fresenius Kabi; Equity ownership in Eluciderm. Sridhar V. Basavaraju: None. Arthur Bracey: Associate Editor, Transfusion; American Red Cross Medical Advisory Committee; Common Spirit Health—Blood Therapeutic Clinical Council. Andrew Cap: Consultancy from Velico Medical; Equity ownership in Velico Medical; Associate Editor, Transfusion. Liz Culler: None. Nancy Dunbar: None. Mary Homer: None. Iris Isufi: Honoraria from Gilead Sciences; consultancies to Bristol-Myers Squibb Company, Janssen Biotech, Inc, ADC Therapeutics, Abbvie, Inc, Caribou Biosciences, Genmab Inc, and Incyte Corporation. Rob Macedo: None. Tanya Petraszko: Abstract Review Committee, AABB. Glenn Ramsey: Honorarium from Immucor, Inc. Christopher A. Tormey: None. Richard Kaufman: Consultancy to Belmont Medical Technologies; Data monitoring committee, Cellphire Therapeutics; Editor-in-Chief, Transfusion. Edward Snyder: Contracted research sponsored by Cerus, Corp; Associate Editor, Transfusion; Medical Advisory Council, American Red Cross. Data S1. Supporting Information. Data S2. Supporting Information. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.